295 related articles for article (PubMed ID: 22135173)
21. Combined resection of the liver and pancreas for malignancy.
Hemming AW; Magliocca JF; Fujita S; Kayler LK; Hochwald S; Zendejas I; Kim RD
J Am Coll Surg; 2010 May; 210(5):808-14, 814-6. PubMed ID: 20421055
[TBL] [Abstract][Full Text] [Related]
22. Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes.
Cusati D; Zhang L; Harmsen WS; Hu A; Farnell MB; Nagorney DM; Donohue JH; Que FG; Reid-Lombardo KM; Kendrick ML
J Am Coll Surg; 2012 Jul; 215(1):117-24; discussion 124-5. PubMed ID: 22726741
[TBL] [Abstract][Full Text] [Related]
23. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
24. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
25. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.
You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW
Eur J Surg Oncol; 2009 Jul; 35(7):728-33. PubMed ID: 19188040
[TBL] [Abstract][Full Text] [Related]
26. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
27. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
28. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
29. Metastectomy for non-colorectal, non-neuroendocrine liver secondaries.
Teo MC; Tan YM; Chung AY; Chow PK; Cheow PC; Soo KC; Hee SW; Ooi LL
ANZ J Surg; 2006 Jul; 76(7):575-8. PubMed ID: 16813621
[TBL] [Abstract][Full Text] [Related]
30. A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.
Pachera S; Yokoyama Y; Nishio H; Oda K; Ebata T; Igami T; Abe T; Shingu Y; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(5):692-8. PubMed ID: 19267257
[TBL] [Abstract][Full Text] [Related]
31. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
32. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
Pawlik TM; Gleisner AL; Bauer TW; Adams RB; Reddy SK; Clary BM; Martin RC; Scoggins CR; Tanabe KK; Michaelson JS; Kooby DA; Staley CA; Schulick RD; Vauthey JN; Abdalla EK; Curley SA; Choti MA; Elias D
Ann Surg Oncol; 2007 Oct; 14(10):2807-16. PubMed ID: 17551795
[TBL] [Abstract][Full Text] [Related]
33. Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience.
Bonney GK; Gomez D; Rahman SH; Verbeke CS; Prasad KR; Toogood GJ; Lodge JP; Menon KV
JOP; 2008 Jan; 9(1):19-25. PubMed ID: 18182738
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
36. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
[TBL] [Abstract][Full Text] [Related]
38. Outcome of surgery for pancreatic neuroendocrine neoplasms.
Fischer L; Bergmann F; Schimmack S; Hinz U; Prieß S; Müller-Stich BP; Werner J; Hackert T; Büchler MW
Br J Surg; 2014 Oct; 101(11):1405-12. PubMed ID: 25132004
[TBL] [Abstract][Full Text] [Related]
39. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
40. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]